11 stories found
A comparative analysis examines the investment potential of Incyte Corporation and Revolution Medicines as both companies pursue promising KRAS-targeted therapies in the competitive biotech sector.
On World Lung Cancer Day, it is emphasized that modern targeted therapies, guided by detailed genetic analysis, allow doctors to select personalized treatments for lung cancer patients. Approximately 6,800 people are diagnosed with lung cancer annually in the Czech Republic.
Genomics and precision medicine are rapidly transforming the prevention, diagnosis, and treatment of cardiovascular diseases, enabling early identification of high-risk individuals and the development of targeted therapies.
A researcher at the University of Oulu has been awarded a grant exceeding one million euros to advance the development of new and more effective cancer treatments and improve the long-term effects of targeted therapies.
Researchers have published the most comprehensive genetic map of autism spectrum disorder to date, identifying key biological pathways linked to the condition. The findings could accelerate the development of targeted treatments for individuals on the spectrum.
An article discusses effective treatments for neck and décolletage lines, emphasizing a combination of proper skincare and targeted therapies.
Progress in targeted therapies and immune-boosting drugs is enabling more individuals, like Cathy Smithwick who has lived with cancer for over 20 years, to manage and live longer with the disease.
Advanced renal cell carcinoma (aRCC) is a heterogeneous disease with complex biological behavior. Over the past 15 years, its therapeutic management has radically changed thanks to the development of targeted therapies.
The FDA has granted approval for Johnson & Johnson's Imaavy, marking a significant treatment option for patients suffering from warm autoimmune hemolytic anemia. This approval expands therapeutic choices for a rare blood disorder previously lacking targeted therapies.
New data published in 2026 indicates a significant advancement in Amyotrophic Lateral Sclerosis (ALS) research, focusing on targeted therapies and genetics. This marks a historic shift in the approach to treating the disease.
Hungarian researchers have developed a new family of molecules that allows for the precise, light-controlled activation of drugs, potentially revolutionizing targeted therapies.